Published in Eur Arch Psychiatry Clin Neurosci on October 31, 2012
Signs of current suicidality in men: A systematic review. PLoS One (2017) 0.75
The glutamate system as a therapeutic target and impact of genes on suicidality. Eur Arch Psychiatry Clin Neurosci (2013) 0.75
Role of genotype in the cycle of violence in maltreated children. Science (2002) 13.50
Suicide. Lancet (2009) 5.90
Toward a clinical model of suicidal behavior in psychiatric patients. Am J Psychiatry (1999) 5.29
Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science (1993) 5.05
Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science (1995) 4.59
Neurobiology of suicidal behaviour. Nat Rev Neurosci (2003) 4.25
MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry (2006) 4.16
Monoamine oxidase: from genes to behavior. Annu Rev Neurosci (1999) 3.48
Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry (2004) 2.84
Suicide attempts, plans, and ideation in culturally diverse sites: the WHO SUPRE-MISS community survey. Psychol Med (2005) 2.49
Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry (1996) 2.43
Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet (2005) 2.43
MAOA and the "cycle of violence:" childhood abuse and neglect, MAOA genotype, and risk for violent and antisocial behavior. Biol Psychiatry (2006) 2.33
A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res (2000) 1.67
Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet (1991) 1.56
Early trauma and increased risk for physical aggression during adulthood: the moderating role of MAOA genotype. PLoS One (2007) 1.46
The gender gap in suicide and premature death or: why are men so vulnerable? Eur Arch Psychiatry Clin Neurosci (2003) 1.42
Genetics of suicide. Mol Psychiatry (2006) 1.34
MAOA genotype, maltreatment, and aggressive behavior: the changing impact of genotype at varying levels of trauma. Biol Psychiatry (2008) 1.32
Personality and attempted suicide. Analysis of anger, aggression and impulsivity. J Psychiatr Res (2009) 1.26
Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors. Am J Med Genet B Neuropsychiatr Genet (2007) 1.25
Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry (1999) 1.25
Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport (2008) 1.21
Suicidal behavior prevention: WHO perspectives on research. Am J Med Genet C Semin Med Genet (2005) 1.14
The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. Eur Arch Psychiatry Clin Neurosci (2010) 1.07
A functional single nucleotide polymorphism (V158M) in the COMT gene is associated with aggressive personality traits. Biol Psychiatry (2003) 1.07
The predictive validation of a suicide intent scale: a five year follow-up. Br J Psychiatry (1981) 1.07
Association of anger-related traits with SNPs in the TPH gene. Mol Psychiatry (2002) 1.06
The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies? Transl Psychiatry (2011) 1.04
The VNTR 2 repeat in MAOA and delinquent behavior in adolescence and young adulthood: associations and MAOA promoter activity. Eur J Hum Genet (2008) 1.03
Prevention of male suicides: lessons from Gotland study. Lancet (1995) 1.00
Genetic determinants of aggression and impulsivity in humans. J Appl Genet (2011) 0.98
Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am J Med Genet B Neuropsychiatr Genet (2003) 0.94
High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport (2002) 0.94
Personality traits as intermediary phenotypes in suicidal behavior: genetic issues. Am J Med Genet C Semin Med Genet (2005) 0.94
Structure and promoter organization of the human monoamine oxidase A and B genes. J Psychiatry Neurosci (1993) 0.93
Nature and nurture in suicidal behavior, the role of genetics: some novel findings concerning personality traits and neural conduction. Physiol Behav (2007) 0.91
Measuring the experience, expression, and control of anger. Issues Compr Pediatr Nurs (1996) 0.89
Cognitive reactivity: investigation of a potentially treatable marker of suicide risk in depression. J Affect Disord (2009) 0.89
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. Am J Med Genet B Neuropsychiatr Genet (2007) 0.88
The monoamine oxidase B gene exhibits significant association to ADHD. Am J Med Genet B Neuropsychiatr Genet (2008) 0.87
Monoamine oxidases: activities, genotypes and the shaping of behaviour. J Neural Transm (Vienna) (2007) 0.85
Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans. J Neural Transm (Vienna) (2009) 0.85
A cis-phase interaction study of genetic variants within the MAOA gene in major depressive disorder. Biol Psychiatry (2010) 0.85
Suicide risk at juvenile justice intake. Suicide Life Threat Behav (2006) 0.84
Central nervous system serotonergic responsivity and aggressive disposition in men. Physiol Behav (2002) 0.84
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2012) 0.84
[A questionnaire for assessing anger and expression of anger]. Z Klin Psychol Psychopathol Psychother (1991) 0.83
NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet (2008) 0.82
Association between monoamine oxidase (MAO)-A gene variants and schizophrenia in a Chinese population. Brain Res (2009) 0.82
Heritability of hostility-related emotions, attitudes, and behaviors. J Behav Med (1993) 0.82
A monoamine oxidase B gene variant and short-term antidepressant treatment response. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.82
Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder. J Clin Psychiatry (1999) 0.81
Tachykinin receptor 1 variants associated with aggression in suicidal behavior. Am J Med Genet B Neuropsychiatr Genet (2007) 0.81
The genetics of neurosystems in mental ill-health and suicidality: beyond serotonin. Eur Psychiatry (2010) 0.79
Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response. J Affect Disord (2011) 0.79
Monoamine oxidase A gene polymorphism and suicide: an association study and meta-analysis. J Affect Disord (2011) 0.79
MAOA haplotypes associated with thrombocyte-MAO activity. BMC Genet (2005) 0.78
The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr Genet (2005) 0.77
CREB1 modulates the influence of childhood sexual abuse on adult's anger traits. Genes Brain Behav (2012) 0.77
Psychopharmacology of borderline personality disorder. Curr Psychiatry Rep (2004) 0.76
Platelet monoamine oxidase activity and psychometric correlates in male violent offenders imprisoned for homicide or other violent acts. Eur Arch Psychiatry Clin Neurosci (2004) 0.76
Associations of MAOA-VNTR or 5HTT-LPR alleles with attention-deficit hyperactivity disorder symptoms are moderated by platelet monoamine oxidase B activity. Psychiatr Genet (2012) 0.75
Large recurrent microdeletions associated with schizophrenia. Nature (2008) 20.25
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15
Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet (2008) 10.52
Common variants conferring risk of schizophrenia. Nature (2009) 10.37
Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med (2012) 10.16
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49
A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet (2009) 5.01
Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet (2008) 4.78
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res (2010) 3.46
D-dimer levels and risk of recurrent venous thromboembolism. JAMA (2003) 3.30
A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry (2013) 2.93
Mindfulness-based stress reduction for stress management in healthy people: a review and meta-analysis. J Altern Complement Med (2009) 2.89
Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet (2013) 2.68
Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS One (2010) 2.57
A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med (2009) 2.37
Higher glucose levels associated with lower memory and reduced hippocampal microstructure. Neurology (2013) 2.33
Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull (2009) 2.25
Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet (2011) 2.21
Does mindfulness training improve cognitive abilities? A systematic review of neuropsychological findings. Clin Psychol Rev (2010) 2.17
The epidemiology of the dementias: an update. Curr Opin Psychiatry (2007) 2.05
Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res (2010) 1.98
The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry (2013) 1.97
Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet (2013) 1.96
Maternally derived microduplications at 15q11-q13: implication of imprinted genes in psychotic illness. Am J Psychiatry (2011) 1.94
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet (2011) 1.88
Genomewide association analysis followed by a replication study implicates a novel candidate gene for neuroticism. Arch Gen Psychiatry (2008) 1.75
Factor structure and external validity of the PANSS revisited. Schizophr Res (2005) 1.74
The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci (2012) 1.70
Late-life body mass index and dementia incidence: nine-year follow-up data from the Kungsholmen Project. J Am Geriatr Soc (2007) 1.65
Penetrance for copy number variants associated with schizophrenia. Hum Mol Genet (2010) 1.64
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One (2010) 1.62
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry (2007) 1.60
A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry (2006) 1.57
Mindfulness-based interventions for chronic pain: a systematic review of the evidence. J Altern Complement Med (2011) 1.54
Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment. Am J Gastroenterol (2003) 1.54
The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J Neurochem (2005) 1.51
Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. Am J Med Genet B Neuropsychiatr Genet (2003) 1.50
Commonalities and variations in the Cash and Counseling programs across the three demonstration States. Health Serv Res (2007) 1.50
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. Eur Arch Psychiatry Clin Neurosci (2012) 1.49
Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate. Cardiovasc Intervent Radiol (2005) 1.49
The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up. Am J Psychiatry (2013) 1.48
Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia. Cell (2012) 1.48
Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Biol Psychiatry (2003) 1.48
Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia. Arch Gen Psychiatry (2010) 1.46
Antihypertensive therapy is associated with reduced rate of conversion to Alzheimer's disease in midregional proatrial natriuretic peptide stratified subjects with mild cognitive impairment. Biol Psychiatry (2011) 1.43
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia. J Clin Psychopharmacol (2015) 1.42
Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. J Clin Psychopharmacol (2005) 1.41
Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch Gen Psychiatry (2008) 1.39
Correction: Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate. PLoS Genet (2015) 1.39
Seasonal variations of lithium plasma levels. Psychiatry Res (2002) 1.38
Are mindfulness-based interventions effective for substance use disorders? A systematic review of the evidence. Subst Use Misuse (2013) 1.37
Actimetric evidence that CLOCK 3111 T/C SNP influences sleep and activity patterns in patients affected by bipolar depression. Am J Med Genet B Neuropsychiatr Genet (2007) 1.35
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy. Eur Neuropsychopharmacol (2011) 1.33
Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care (2004) 1.32
Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci Biobehav Rev (2006) 1.30
Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum Genet (2006) 1.29